See also this year's filing and all EDGAR filings for this company.
PDF Report 0001261249_2020_AGILE_THERAPEUTICS_INC.pdf
Logs
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001261249')"} |
Graph
Absolute values for 0001261249, AGILE THERAPEUTICS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 35,319,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 14,044,000 |
| 3 | remainder_Assets | 177,000 |
| 4 | LiabilitiesCurrent | 3,795,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,000,000 |
| 9 | ResearchAndDevelopmentExpense | 9,858,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 252,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 49,540,000 |
| 1 | Liabilities | 3,795,000 |
| 2 | Expenses | 18,858,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 45,745,000 |
| 5 | NetIncome | -18,606,000 |
| 6 | ComprehensiveNetIncome | -18,606,000 |
| 7 | BaseVar | 36,222,500 |
| 8 | EconomicCapitalRatio | 2.25 |